For both cost functions a high initial drug dose in the full model rapidly reduces overall cancer levels, but produces much higher levels of the drug-immune CD38- population, and recovery of the healthy cell population is inhibited by the off-target effect while the control dose is high. This evidence concerns the gene CD38 and cancer.